Pharmaceutical health services scholars at the University of Maryland School of Pharmacy have found that a decade-old federal policy meant to reduce antipsychotic medication usage led to several unintended consequences.
Danya Qato, PhD, PharmD, MPH, associate professor in the Department of Practice, Sciences, and Health Outcomes Research (P-SHOR), and Linda Wastila, PhD, MPH, professor in P-SHOR and the Parke-Davis Chair in Geriatric Pharmacotherapy, have been researching the effects of the policy, called the antipsychotic reduction initiative (ARI), as part of their work with the School’s Peter Lamy Center on Drug Therapy and Aging.
Read the full story on the School of Pharmacy's News Center.